An Unusual Presentation of New Onset Sarcoidosis
DOI:
https://doi.org/10.17140/PRRMOJ-6-140Keywords:
Weight loss, Hilar lymphadenopathy, Confusion, Fatigue, Shortness of breath (SoB)Abstract
This paper summarizes the case of a patient admitted to the hospital for nausea, light-headedness, and vomiting in the setting of persistent leukocytosis. Despite being adequately treated for an infection, the patient’s leukocytosis did not resolve. Workup yielded a diagnosis of sarcoidosis. This is an unusual presentation of sarcoidosis since the patient did not present with typical respiratory symptoms. The presenting dyspnea on exertion is thought to be due to his smoking history. Treatment is promptly initiated with steroids. It is of utmost importance to initiate steroid therapy to prevent the progression of the disease. Sequelae may include glaucoma, small-fiber neuropathy, and pain syndromes.
References
Sève P, Pacheco Y, Durupt F, et al. Sarcoidosis: A clinical overview from symptoms to diagnosis. Cells. 2021; 10: 766. doi: 10.3390/cells10040766
Han YS, Rivera-Grana E, Salek S, Rosenbaum JT. Distin-guishing uveitis secondary to sarcoidosis from idiopathic disease. JAMA Ophthalmol. 2018; 136: 109. doi: 10.1001/jamaophthal-mol.2017.5466 Submit your article to this journal | https://openventio.org/submit-manuscript/ Case Report | Volume 6 | Issue 1 | Dresser C, et al
Gerke AK. Treatment of sarcoidosis: A multidisciplinary ap-proach. Front Immunol. 2023; 11: 545413. doi: 10.3389/fim-mu.2020.545413
Basma MM, Mervat EB, Mohamed F, et al. Sarcoidosis be-yond pulmonary involvement: A case series of unusual pres-entations. Respir Med Case Rep. 2021; 34: 101495. doi: 10.1016/j. rmcr.2021.101495
Belperio JA, Shaikh F, Abtin FG, et al. Diagnosis and treatment of pulmonary sarcoidosis: A review. JAMA. 2022; 327: 856-867. doi: 10.1001/jama.2022.1570
Downloads
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
All content published in Pulmonary Research and Respiratory Medicine (PRRM) is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows anyone to copy, distribute, transmit, and adapt the work — including for commercial purposes — provided appropriate credit is given to the original author(s) and source.